Comparison between Amagi Media Labs IPO and Indira IVF IPO.
Amagi Media Labs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Indira IVF IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Amagi Media Labs IPO is up to ₹1,788.62 Cr whereas the issue size of the Indira IVF IPO is up to ₹0.00 Cr. The final issue price of Amagi Media Labs IPO is ₹361.00 per share and of Indira IVF IPO is .
| Amagi Media Labs IPO | Indira IVF IPO | |
|---|---|---|
| Face Value | ₹5 per share | |
| Issue Price (Lower) | ₹343.00 per share | |
| Issue Price (Upper) | ₹361.00 per share | |
| Issue Price (Final) | ₹361.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 41 shares | |
| Fresh Issue Size | 2,26,03,878 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹816.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 2,69,42,343 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹972.62 Cr | up to ₹0.00 Cr |
| Issue Size Total | 4,95,46,221 shares | 0 shares |
| Issue Size Total (Amount) | up to ₹1,788.62 Cr | up to ₹0.00 Cr |
Amagi Media Labs IPO opens on Jan 13, 2026, while Indira IVF IPO opens on . The closing date of Amagi Media Labs IPO and Indira IVF IPO is Jan 16, 2026, and , respectively.
| Amagi Media Labs IPO | Indira IVF IPO | |
|---|---|---|
| Anchor Bid Date | Jan 12, 2026 | |
| Issue Open | Jan 13, 2026 | |
| Issue Close | Jan 16, 2026 | |
| Basis Of Allotment (Tentative) | Jan 19, 2026 | |
| Initiation of Refunds (Tentative) | Jan 20, 2026 | |
| Credit of Share (Tentative) | Jan 20, 2026 | |
| Listing date (Tentative) | Jan 21, 2026 | |
| Anchor Lockin End date 1 | Feb 17, 2026 | |
| Anchor Lockin End date 2 | Apr 18, 2026 |
Amagi Media Labs IPO P/E ratio is -101.78, as compared to Indira IVF IPO P/E ratio of .
| Amagi Media Labs IPO | Indira IVF IPO | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials ()
| |||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 15.76 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 14.14 | ||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | -101.78 | ||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹7809.84 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | |||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹-3.55 | ||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -13.49% | ||||||||||||||||||||||||||||||||||||||||||||||||
In the Amagi Media Labs IPO Retail Individual Investors (RII) are offered 49,54,622 shares while in Indira IVF IPO retail investors are offered 49,54,622 shares. Qualified Institutional Buyers (QIB) are offered 1,48,63,867 shares in Amagi Media Labs IPO and in Indira IVF IPO.
| Amagi Media Labs IPO | Indira IVF IPO | |
|---|---|---|
| Anchor Investor Reservation | 2,22,95,799 shares | |
| Market Maker Reservation | 0 shares | |
| QIB | 1,48,63,867 shares | |
| NII | 74,31,933 shares | |
| RII | 49,54,622 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 4,95,46,221 shares |
Amagi Media Labs IPO subscribed 30.24x in total, whereas Indira IVF IPO subscribed .
| Amagi Media Labs IPO | Indira IVF IPO | |
|---|---|---|
| QIB (times) | 33.13x | |
| NII (times) | 38.26x | |
| Big NII (times) | 44.24x | |
| Small NII (times) | 26.29x | |
| RII (times) | 9.54x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 30.24x |
